Market Place
Sourcing Support
Galecto bags $64M to push lung fibrosis med toward EU nod
26 Sep 2020 //
FIERCE BIOTECH
EU, US biotechs merge to create fibrosis, cancer player
08 Jan 2020 //
PM LIVES
Galecto to merge with onetime Celgene partner PharmAkea
08 Jan 2020 //
FIERCE BIOTECH
EU, US biotechs merge to create fibrosis, cancer player
07 Jan 2020 //
PM LIVES
EU, US biotechs merge to create fibrosis, cancer player
07 Jan 2020 //
PM LIVES
Galecto to merge with one-time Celgene partner PharmAkea
07 Jan 2020 //
FIERCE BIOTECH
Ectonucleotide Pyrophosphatase/Autotaxin Pipeline Review Studied & Analyzed
14 Jun 2018 //
DIGITALJOURNAL
PharmAkea Completion Ph1 Trial in Healthy Subjects LOXL2 Inhibitor, PAT-1251
22 Aug 2017 //
PRESS RELEASE
Celgene, PharmAkea Extend Fibrotic Disease Drug Alliance
18 Nov 2016 //
GENENGNEWS
Pushing Forward With Collab R&D Models In Biotech: Roche-Spero & Biogen-Ataxion
09 Apr 2014 //
FORBES
PharmAkea raises $45 million
18 Oct 2013 //
SANDIEGOUNIONTRIBUNE
Celgene forges $35M cancer, fibrosis discovery pact with PharmAkea
04 Oct 2013 //
FIERCE BIOTECH
PharmAkea, Celgene Corporation & Bay City Capital Collaborate
04 Oct 2013 //
MARKETWIRED
Copyright © 2025 LePro PharmaCompass OPC Private Limited, All rights reserved.